Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 3.39 USD 1.19% Market Closed
Updated: May 30, 2024

Mereo Biopharma Group PLC
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mereo Biopharma Group PLC
Depreciation & Amortization Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Mereo Biopharma Group PLC
NASDAQ:MREO
Depreciation & Amortization
£730k
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Depreciation & Amortization
$810k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Depreciation & Amortization
$6.6m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Depreciation & Amortization
$6.6m
CAGR 3-Years
72%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Depreciation & Amortization
£4.1m
CAGR 3-Years
-23%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Depreciation & Amortization
£45.1m
CAGR 3-Years
6%
CAGR 5-Years
13%
CAGR 10-Years
15%

See Also

What is Mereo Biopharma Group PLC's Depreciation & Amortization?
Depreciation & Amortization
730k GBP

Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Depreciation & Amortization amounts to 730k GBP.

What is Mereo Biopharma Group PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
-23%

Over the last year, the Depreciation & Amortization growth was 14%. The average annual Depreciation & Amortization growth rates for Mereo Biopharma Group PLC have been -23% over the past three years .